Previous Article | Next Article 
Journal of Virology, March 2000, p. 2550-2557, Vol. 74, No. 6
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
The Epstein-Barr Virus Pol Catalytic Subunit Physically Interacts
with the BBLF4-BSLF1-BBLF2/3 Complex
Ken
Fujii,1,2
Naoaki
Yokoyama,1
Tohru
Kiyono,1
Kiyotaka
Kuzushima,1
Michio
Homma,2
Yukihiro
Nishiyama,3
Masatoshi
Fujita,1 and
Tatsuya
Tsurumi1,*
Division of Virology, Aichi Cancer Center Research
Institute, Chikusa-ku, Nagoya 464-8681,1
Division of Biological Science, Nagoya University Graduate
School of Science, Chikusa-ku, Nagoya 464-8602,2
and Laboratory of Virology, Nagoya University School of
Medicine, Showa-ku, Nagoya 466-8550,3 Japan
Received 13 September 1999/Accepted 22 December 1999
 |
ABSTRACT |
The Epstein-Barr virus (EBV)-encoded replication proteins that
account for the basic reactions at the replication fork are thought to
be the EBV Pol holoenzyme, consisting of the BALF5 Pol catalytic and
the BMRF1 Pol accessory subunits, the putative helicase-primase
complex, comprising the BBLF4, BSLF1, and BBLF2/3 proteins, and the
BALF2 single-stranded DNA-binding protein. Immunoprecipitation analyses
using anti-BSLF1 or anti-BBLF2/3 protein-specific antibody with
clarified lysates of B95-8 cells in a viral productive cycle suggested
that the EBV Pol holoenzyme physically interacts with the
BBLF4-BSLF1-BBLF2/3 complex to form a large complex. Although the
complex was stable in 500 mM NaCl and 1% NP-40, the BALF5 protein
became dissociated in the presence of 0.1% sodium dodecyl sulfate.
Experiments using lysates from insect cells superinfected with
combinations of recombinant baculoviruses capable of expressing each of
viral replication proteins showed that not the BMRF1 Pol accessory
subunit but rather the BALF5 Pol catalytic subunit directly interacts
with the BBLF4-BSLF1-BBLF2/3 complex. Furthermore, double infection
with pairs of recombinant viruses revealed that each component of the
BBLF4-BSLF1-BBLF2/3 complex makes contact with the BALF5 Pol catalytic
subunit. The interactions of the EBV DNA polymerase with the EBV
putative helicase-primase complex warrant particular attention because
they are thought to coordinate leading- and lagging-strand DNA
synthesis at the replication fork.
 |
INTRODUCTION |
Epstein-Barr virus (EBV) is a human
B-lymphotropic herpesvirus which is a causative agent of infectious
mononucleosis and is known to be closely associated with several
human cancers, including nasopharyngeal carcinoma and Burkitt's
lymphoma. The EBV genome is a linear double-stranded DNA which is 172 kbp in length (2). Like other herpesviruses, EBV has both a
latent state and a lytic replication cycle. In latently infected
lymphoblastoid cells, the viral genome is maintained as a circular
plasmid molecule and replicated by the replication machinery of the
host (1, 46). However, after induction of lytic viral
replication, EBV DNA replication proteins are induced and the EBV
genome is amplified 100- to 1,000-fold via the lytic-phase replication
origin, oriLyt. The intermediate replication product is a large
concatemeric molecule in which single genome units are arranged head to
tail (15).
EBV encodes seven viral replication genes that are essential for
oriLyt-dependent DNA replication (11, 12). The BZLF1 protein
is an oriLyt-binding protein and also acts as the lytic transactivator
(31). The BALF5 gene encodes the DNA Pol catalytic subunit
(43), and the BMRF1 gene encodes the DNA Pol accessory subunit (19, 39, 40, 41). A single-stranded DNA
(ssDNA)-binding protein is encoded by the BALF2 gene (42,
44). The enzymatic activities of the remaining three proteins
encoded by the BBLF4, BSLF1, and BBLF2/3 genes have not been
determined, but they are predicted to act as helicase, primase, and
helicase-primase complex proteins, respectively, from sequence homology
to the herpes simplex virus type 1 (HSV-1) UL5, UL52, and UL8 genes
(12). These viral replication proteins other than BZLF1
protein conceivably work together at replication forks to synthesize
leading and lagging strands of the concatemeric EBV genome.
The BALF5 Pol catalytic polypeptide is copurified with the BMRF1 Pol
accessory subunit from EBV-producing lymphoblastoid cells (18, 21,
37), as demonstrated by immunoprecipitation with anti-BALF5
Pol-specific antibody (48), appearing to function as a Pol
holoenzyme which exhibits both 5'-to-3' DNA polymerase and 3'-to-5'
exonuclease activities (37). In addition, this EBV DNA Pol
holoenzyme is characterized by strikingly high polymerase processivity
(38, 40). Although the BALF5 Pol catalytic subunit by itself
is a quasi-processive enzyme (40), complexed together with
the BMRF1 Pol accessory subunit, it demonstrates stable interaction with the 3'-OH end of the primer on template DNA during polymerization and exonucleolysis (40, 41). oriLyt-dependent DNA
replication would be best served by a highly processive DNA polymerase
which could synthesize long DNA chains without dissociating from the template.
The BALF2 gene product has an apparent molecular weight on sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) of
130,000 (predicted molecular weight, 123,122) and contains a
series of motifs that are conserved in a number of ssDNA-binding proteins (45). The BALF2 protein binds to ssDNA
preferentially and possesses helix-destabilizing property (42,
44). The BALF2 protein greatly enhances DNA synthesis catalyzed
by the EBV BALF5 Pol catalytic subunit on a primed M13 ssDNA template,
suggesting functional interaction between the EBV DNA polymerase and
the EBV ssDNA-binding protein (44).
As noted above, the enzymatic activities of the BBLF4,
BSLF1, and BBLF2/3 proteins have yet to be demonstrated, but the BBLF4 and BSLF1 gene products share 34 and 23% sequence identities with HSV-1 UL5 and UL52 gene products and are composed of 810 and 875 amino
acids (predicted relative molecular weights of 89,795 and 97,972),
respectively. Although the BBLF2/3 gene product has no significant
similarity with HSV-1 UL8 gene product in overall identity, it has
one stretch of 55 amino acids which are similar to the UL8 protein
(11). The BBLF2/3 gene product is translated from one
spliced RNA derived from the two open reading frames, BBLF2 and BBLF3,
and is composed of 710 amino acids (predicted relative molecular weight
of 78,176). Few studies characterizing the EBV putative
helicase-primase have been performed. Gao et al. (14)
have provided evidence of the BSLF1-BBLF4-BBLF2/3 complexes through immunofluorescence assays with nuclear retranslocation. They expressed the three BBLF4, BSLF1, and BBLF2/3 proteins fused to the Myc epitope in Vero cells by transfecting their expression vectors. When individually transfected, Myc-BBLF2/3 showed mixed nuclear and cytoplasmic staining, Myc-BSLF1 was perinuclear, and Myc-BBLF4 localized to the cytoplasm. The concurrent presence of the
all three members resulted in nuclear localization of the BBLF4,
BBLF2/3, and BSLF1 proteins, suggesting the existence of a
BSLF1-BBLF4-BBLF2/3 complex. Recently we have directly
demonstrated and confirmed the assembly of the BBLF4, BSLF1, and
BBLF2/3 proteins in the lytic phase of B95-8 cells by
immunoprecipitation analyses (47). Furthermore, we designed
baculovirus expression systems for the BBLF4, BSLF1, and BBLF2/3
proteins to characterize the direct protein-protein interactions
among these proteins in infected insect cells and could reproduce their
complex formation in recombinant baculovirus expression systems.
Experiments performed with double infection of pairs of recombinant
viruses revealed that each component of the BBLF4-BSLF1-BBLF2/3 complex
interacts directly with the other two (47).
The economy of proteins involved in replication of the EBV genome has
made it an attractive model for dissecting the protein-protein interactions that are essential for coordination of the multiple reactions that occur at a replication fork. The specific interactions that occur among the six replication proteins appear to be essential for EBV DNA replication. In this report, we document our findings for
direct interactions of the EBV DNA DNA polymerase and the EBV putative
helicase-primase complex.
 |
MATERIALS AND METHODS |
Cells.
B95-8 cells, a marmoset lymphoblastoid cell line
immortalized with a human EBV, were grown at 37°C in a 5%
CO2 atmosphere in RPMI 1640 medium (Life Technologies,
Inc.) supplemented with 40 µg of kanamycin per ml and 10% fetal calf
serum. Spodoptera frugiperda (Sf9) and Trichoplusia
ni (High Five) insect cells were grown at 27°C in Sf-900 IISFM
and Express Five SFM media (Life Technologies), respectively,
supplemented with 20 µg of gentamicin per ml and 10% fetal calf serum.
Preparation of the recombinant baculoviruses.
Construction of the recombinant baculoviruses AcBALF5, AcBMRF1,
AcBALF2, AcBBLF4, AcBSLF1, and AcBBLF2/3, expressing BALF5, BMRF1,
BALF2, BBLF4, BSLF1, and BBLF2/3 gene products, respectively, was
described previously (39, 42, 43, 47). Stocks of recombinant viruses were prepared by infecting monolayers of Sf9 cells grown to a
multiplicity of infection (MOI) of 0.1 PFU/cell. After incubation for 4 days, the cells were pelleted by centrifugation at 1,500 × g for 10 min at 4°C, and the virus in the supernatant fluid was
either used directly or frozen at
80°C. The final viral titers were
approximately 107 to 108 PFU/ml.
Antibodies.
The seven viral replication protein-specific
antibodies (purified immunoglobulin G [IgG]) were used for
immunoprecipitation and Western blotting analyses. BALF5
protein-specific rabbit antibody was produced against a truncated
region of the EBV BALF5 protein containing a 3'-to-5' exonuclease
domain and a nucleotide binding domain (361 amino acids) as described
previously (43). BMRF1 protein-specific mouse monoclonal
antibody was purchased from NEN/Dupont Inc. (29). BZLF1
protein-specific mouse monoclonal antibody was purchased from DAKO Inc.
BALF2 protein-specific antibody was produced against the
carboxyl-terminal two-thirds of the EBV BALF2 protein (699 amino acids)
as described previously (44). BSLF1c, BBLF4, and BBLF2/3w
protein-specific rabbit antibodies were produced against the BSLF1
carboxy-terminal region (504 amino acids), the BBLF4 carboxy-terminal
oligopeptide (20 amino acids), and whole BBLF2/3 gene products,
respectively, as described previously (43, 47).
Coupling the anti-BBLF2/3w antibody to protein A beads.
The
anti-BBLF2/3w antibody was coupled to protein A beads according to
standard procedures (16). Briefly, 500 µl of protein A-agarose beads (Amersham Pharmacia Biotech Inc.) was mixed with 500 µg of the anti-BBLF2/3w IgG or normal rabbit IgG (DAKO) and gently
rocked for 1 h at room temperature (RT). The protein A-antibody beads were washed four times with 5 ml of 0.2 M sodium borate adjusted
to pH 9.0 and resuspended in 10 ml of 0.2 M sodium borate (pH 9.0).
After addition of dimethylpimelidate dihydrochloride to a final
concentration of 20 mM, the beads were gently rocked for 30 min at RT
and washed twice with 10 ml of ethanolamine adjusted to pH 8.0. After
being suspended in 10 ml of ethanolamine and rocked for 2 h at RT,
the coupled beads were washed twice with 5 ml of distilled water and
0.5 ml of 0.1 M glycine-HCl (pH 2.5). The coupled beads were then
suspended in 5 ml of phosphate-buffered saline (PBS) and stored at
4°C until used.
Preparation of lysate from B95-8 cells in the virus productive
cycle.
B95-8 cells were seeded at 3 × 106
cells/ml in 30 ml of culture medium with 200 ng of phorbol 12-myristate
13-acetate, 5 mM sodium n-butyrate, and 1 µM calcium
ionophore A23187 for induction of the EBV lytic replication cycle. At
72 h postinduction, the cells were harvested and washed with cold
PBS. Pellets were resuspended in 5 ml of hypotonic buffer (50 mM
Tris-HCl [pH 7.6], 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 1 mM dithiothreitol [DTT], 10 µg each of pepstatin A and leupeptin
per ml), stored on ice for 30 min, subjected to Dounce homogenization
with 30 strokes, and then centrifuged at 1,500 × g for
10 min at 4°C. Nonidet P-40 (NP-40) and sodium chloride were added to
the supernatant to final concentrations of 0.2% and 150 mM,
respectively, followed by centrifugation at 18,000 × g
for 5 min. The clarified lysate was confirmed to contain the BALF5,
BMRF1, BALF2, BSLF1, BBLF4, and BBLF2/3 proteins as judged by Western
blotting analyses using each of the protein-specific antibodies, frozen
in liquid nitrogen, and then stored at
80°C until used for
immunoprecipitation analyses.
Preparation of cell extracts from High Five cells infected with
recombinant baculoviruses.
High Five cells were seeded at
106 cells per well in six-well plates and infected or
coinfected with the indicated recombinant baculovirus(es) at an MOI of
5 PFU per cell for each virus. At 48 h postinfection, the cells
were harvested, washed three times with cold PBS, resuspended in 1 ml
of lysis buffer (50 mM Tris-HCl [pH 8.0], 150 mM NaCl, 1% NP-40, 1 mM phenylmethylsulfonyl fluoride, 1 mM DTT, 10 µg each of pepstatin A
and leupeptin per ml), and incubated on ice for 20 min. The resultant
lysates were centrifuged at 18,000 × g for 10 min at
4°C, and the supernatants were frozen in liquid nitrogen and stored
at
80°C until used for immunoprecipitation analyses.
Immunoprecipitation analyses.
Immunoprecipitation analyses
were performed according to standard procedures (30). The
protein extracts were mixed with indicated antibodies and gently rocked
for 1 h at 4°C. After addition of protein A-agarose beads
(Amersham Pharmacia Biotech), the mixtures were further incubated for
1 h at 4°C, and then the antigen-antibody-protein A bead
complexes were washed six times with 1 ml of NET gel buffer (50 mM
Tris-HCl [pH 7.6], 500 mM NaCl, 1% NP-40, 1 mM EDTA). Each aliquot
of the immunoprecipitated beads was suspended in 70 µl of SDS sample
buffer (62.5 mM Tris-HCl [pH 6.8], 2% SDS, 0.1 M DTT, 10% glycerol,
0.01% bromphenol blue) and heated at 100°C for 6 min. After
centrifugation at 18,000 × g for 5 min, the
supernatants were subjected to SDS-PAGE (6 or 10% polyacrylamide) and
Western blotting analyses, the latter performed as described previously (13). The protein blots transferred onto nitrocellulose
membranes were incubated with the indicated first antibodies for 1 h at RT, subsequently probed with peroxidase-conjugated goat
anti-rabbit IgG (Zymed Laboratories, Inc.) or peroxidase-conjugated
rabbit anti-mouse IgG (Biolabs Inc.) for 1 h at RT, and then
visualized by using enhanced chemiluminescence (NEN Inc.).
 |
RESULTS |
Detection of physical interaction between the EBV Pol
holoenzyme and BBLF4-BSLF1-BBLF2/3 complex in
virus-productive-phase B95-8 cells.
We have reported that EBV
BBLF4, BSLF1, and BBLF2/3 replication proteins are induced and
assembled to form a tripartite complex in B95-8 cells after
induction of the lytic phase of EBV DNA replication (47). To
investigate whether other EBV replication proteins interact with the
BBLF4-BSLF1-BBLF2/3 complex in B95-8 cells in a virus productive cycle,
immunoprecipitations combined with Western blotting analyses were
performed. Antibodies specific for each of the six viral replication
proteins which conceivably work together at replication forks of EBV
were prepared. Anti-BSLF1c and anti-BBLF2/3w rabbit IgGs were used for
immunoprecipitation analyses because they could precipitate effectively
their target proteins but not any of the other viral proteins alone
(see Fig. 4D). As a negative control, normal rabbit IgG was used.
The EBV lytic phase of DNA replication was induced by treatment with a
combination of chemical agents such as phorbol 12-myristate 13-acetate,
sodium n-butyrate, and calcium ionophore A23187, as described previously (47). The cells were harvested at
72 h postinduction, and clarified lysates were prepared and
confirmed to contain the six viral replication proteins (BALF5,
BMRF1, BALF2, BBLF4, BSLF1, and BBLF2/3) and low amounts of BZLF1
origin-binding protein as judged by Western blotting analyses (Fig.
1; see also Fig. 3). The lysates were
subjected to immunoprecipitation analysis with anti-BSLF1c or
anti-BBLF2/3w IgG. The ternary antigen-antibody-protein A complexes
were collected and washed extensively with NET gel buffer containing
500 mM NaCl and 1% NP-40, subjected to SDS-PAGE, and transferred onto
nitrocellulose membranes. Then the protein blots were incubated with
the indicated first antibodies.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 1.
Coprecipitation of the BALF5 Pol catalytic subunit with
the anti-BSLF1c or the anti-BBLF2/3w antibodies from clarified lysates
of B95-8 cells in the virus productive cycle. Cells were harvested at
72 h postinduction, and 5-ml aliquots of clarified lysates were
prepared as described in Materials and Methods. Then 400-µl aliquots
of the lysate were subjected to immunoprecipitation (I.P.) analyses;
3-µg aliquots of the control rabbit IgG, the anti-BSLF1c IgG (A), or
the anti-BBLF2/3w (B) IgG were added to the lysates, and the mixtures
were gently rocked for 1 h at 4°C in the presence of 150 mM NaCl
and 0.2% NP-40. The antigen-antibody complexes were collected with 20 µg of protein A beads, washed six times with NET gel buffer
containing 500 mM NaCl and 1% NP-40, and suspended in 70 µl of
sample buffer for SDS-PAGE. Aliquots of the immunoprecipitated proteins
(10 µl) and lysates (5 µl; Input) were resolved by SDS-PAGE and
analyzed by Western blotting with the anti-BALF5, anti-BSLF1c,
anti-BALF2, or anti-BBLF2/3w IgG. Immunoprecipitated proteins are
indicated by arrowheads.
|
|
The results of immunoprecipitation analyses using the anti-BSLF1c IgG
are shown in Fig. 1A. The control rabbit IgG could not precipitate any
of viral replication proteins from the cell extract. In contrast, the
anti-BSLF1c IgG coprecipitated the 110-kDa (110K) BALF5 Pol catalytic
subunit with the corresponding 89K BSLF1 protein from the B95-8 cell
extracts, although it did not precipitate the BALF5 protein directly
(see Fig. 4D). The anti-BBLF2/3w IgG coimmunoprecipitated the BALF5
protein in addition to the corresponding 80K BBLF2/3 protein from the
cell extract (Fig. 1B) while not precipitating the BALF5 protein
directly (see Fig. 4D). Thus, we demonstrated that the BALF5 protein is
associated with the BSLF1 and BBLF2/3 proteins. In contrast,
neither the anti-BSLF1c nor the anti-BBLF2/3w antibody precipitated
the BALF2 ssDNA-binding protein (Fig. 1). These results and our
previous observation of a tripartite complex consisting of the BBLF4,
BSLF1, and BBLF2/3 proteins (47) strongly suggest that the
EBV BALF5 DNA catalytic subunit is associated with the
BBLF4-BSLF1-BBLF2/3 complex in B95-8 cells after induction of the lytic
phase of EBV DNA replication.
To ascertain the affinity of the BALF5 protein for the
BBLF4-BSLF1-BBLF2/3 complex, the ternary antigen-antibody-protein A complexes were washed extensively under more stringent conditions with NET gel buffer containing 0.5 M NaCl, 1% NP-40, and 0.1% SDS.
The anti-BSLF1c IgG could not precipitate the BALF5 Pol catalytic subunit but did coprecipitate the 80K BBLF2/3 and 90K BBLF4 proteins along with the 89K BSLF1 protein from the B95-8 cell lysate (Fig. 2A). Also, the anti-BBLF2/3w IgG
did not precipitate the BALF5 protein, although the antibody could
precipitate its target protein (Fig. 2B). These results indicate
that the BBLF4, BSLF1, and BBLF2/3 proteins form a very tight
tripartite complex. On the other hand, the association of the BALF5
protein with the BBLF4-BSLF1-BBLF2/3 complex was unstable to 0.1%
SDS-500 mM NaCl-1% NP-40 but stable to 500 mM NaCl-1% NP-40.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 2.
Dissociation of the BALF5 protein from the
BBLF4-BSLF1-BBLF2/3 complex. Clarified lysates from B95-8 cells
in the virus productive cycle were prepared and subjected to
immunoprecipitation (I.P.) analyses; 3 µg of the control rabbit IgG,
the anti-BSLF1c IgG (A), or the anti-BBLF2/3w IgG (B) was added to the
lysates, and the mixtures were incubated as described in the legend to
Fig. 1. The antigen-antibody complexes were collected with 20 µg of
protein A beads and washed six times under more stringent conditions
with NET gel buffer containing 500 mM NaCl, 1% NP-40, and 0.1% SDS.
Aliquots of the immunoprecipitated proteins (10 µl) and lysates (5 µl; Input) were resolved by SDS-PAGE and analyzed by Western blotting
with the anti-BALF5, anti-BSLF1c, anti-BBLF2/3w, or anti-BBLF4 IgG.
Immunoprecipitated proteins are indicated by arrowheads.
|
|
It is known that the BALF5 Pol catalytic subunit is functionally
associated with the BMRF1 accessory subunit, acting as a Pol holoenzyme
(19, 20, 39, 40, 41, 43). Furthermore, Zeng et al.
(48) showed that anti-BALF5 antibody could precipitate the
BMRF1 protein by immunoprecipitation analysis. To investigate whether
the BBLF4-BSLF1-BBLF2/3 complex interacts with the BALF5 Pol catalytic
subunit only or with the EBV Pol holoenzyme, it was determined whether
the immunoprecipitated complex contains the BMRF1 Pol accessory
subunit. In Western blotting analysis using the anti-BMRF1 monoclonal
antibody, a thick band of the rabbit immunoglobulin heavy chain
(molecular weight of about 50,000) used for immunoprecipitation
analysis disturbed detection of the BMRF1 gene products (molecular
weights of 48,000 to 52,000), since the peroxidase-conjugated
anti-mouse IgG cross-reacted with rabbit immunoglobulin heavy chain. To
avoid this problem, we prepared the BBLF2/3-specific IgG coupled to
protein A-Sepharose beads (anti-BBLF2/3 IgG beads) and control
rabbit IgG beads. As shown in Fig. 3, the
control rabbit IgG beads could not precipitate any of the viral
replication proteins from the cell extracts. Although the anti-BBLF2/3
IgG could not directly precipitate replication proteins other than its
own protein (Fig. 4D), the anti-BBLF2/3 IgG beads not only precipitated
the corresponding 80K BBLF2/3 protein but also coprecipitated both 48K
to 52K BMRF1 and BALF5 proteins from the clarified cell extract. The
mobilities of BMRF1 gene products in SDS-PAGE change dependent on the
phosphorylation state (39).

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 3.
(A) Detection of the BMRF1 Pol accessory subunit with
the BALF5 Pol catalytic subunit in the immunoprecipitated proteins by
anti-BBLF2/3w IgG beads from lysates of B95-8 cells in the EBV
productive cycle. Clarified lysates were prepared as described in
Materials and Methods and subjected to immunoprecipitation (I.P.)
analyses; 10 µg of control rabbit IgG or anti-BBLF2/3w IgG beads was
added to the lysates, and the mixtures were incubated as described in
the legend to Fig. 1. The antigen-antibody-bead complexes were washed
six times with NET gel buffer containing 500 mM NaCl and 1% NP-40.
Aliquots of the immunoprecipitated proteins (10 µl) and lysates (5 µl; Input) were resolved by SDS-PAGE and analyzed by Western blotting
with the anti-BMRF1 monoclonal IgG, anti-BALF5 IgG, or anti-BBLF2/3w
rabbit IgG. Immunoprecipitated proteins are indicated by arrowheads.
(B) Fractionation of the BZLF1 protein expressed in B95-8 cells in the
virus productive cycle. Cells were harvested at 72 h postinduction
and homogenized as described in Materials and Methods. The whole cell
lysates (5 ml) were centrifuged for fractionation into clarified
lysates (5 ml) and pellets. The pellets were resuspended in 5 ml of
sample buffer; 5-µl aliquots of each sample were resolved by SDS-PAGE
and analyzed by Western blotting with the anti-BZLF1 protein mouse IgG.
Lane 1, whole cell lysates; lane 2, clarified lysates; lane 3, pelleted
fraction.
|
|
Since the BZLF1 protein physically interacts with the BMRF1 protein
(49) and the BBLF4-BSLF1-BBLF2/3 complex (14), it is possible that the BBLF2/3-specific IgG pulled down the BMRF1 Pol
accessory protein via the BZLF1 protein. Therefore, we examined the
level of the BZLF1 protein in clarified lysates of B95-8 cells with
virus production. As shown by the Western blotting analyses in Fig. 3B,
little of the BZLF1 protein was detected in the lysates but almost all
it was fractionated into the insoluble fraction. Therefore, it is
unlikely that the association of the BMRF1 protein with the
BBLF4-BSLF1-BBLF2/3 complex is mediated by the BZLF1 protein. These
observations strongly suggest that the EBV Pol holoenzyme is physically
associated with the BBLF4-BSLF1-BBLF2/3 complex in B95-8 cells after
induction of the lytic phase of EBV DNA replication.
Direct interaction between the BALF5 Pol catalytic subunit and the
BBLF4-BSLF1-BBLF2/3 complex in High Five insect cells.
To
determine which component of the EBV Pol holoenzyme interacts
with the BBLF4-BSLF1-BBLF2/3 complex, we used recombinant baculovirus
expression systems. High Five insect cells were infected alone or
superinfected with the AcBALF5, AcBBLF4, AcBSLF1, and AcBBLF2/3 recombinant baculoviruses at an MOI of 5 PFU per
cell for each virus and harvested 48 h postinfection. Clarified
cell lysates were prepared, and immunoprecipitation analyses were
performed. The anti-BBLF2/3w IgG could immunoprecipitate the
corresponding BBLF2/3 protein but did not cross-react with the BALF5
Pol catalytic subunit or with the BBLF4 and BSLF1 proteins (Fig.
4D). When insect cells were superinfected
with the four recombinant baculoviruses, the anti-BBLF2/3w IgG
precipitated all of the BALF5, BSLF1, BBLF2/3, and BBLF4 proteins (Fig.
4A). This was not the case with the control rabbit IgG.
On the other hand, immunoprecipitation analysis of the extracts
from cells superinfected with the four recombinant baculoviruses AcBMRF1, AcBSLF1, AcBBLF2/3, and AcBBLF4 revealed that
the anti-BBLF2/3w IgG beads could not precipitate the BMRF1 Pol
accessory subunit (Fig. 4B). These observations clearly indicate that the BALF5 Pol catalytic subunit directly interacts with the BBLF4-BSLF1-BBLF2/3 complex and the BMRF1 Pol accessory subunit does not. In Fig. 3, immunoprecipitation of the BBLF2/3 protein brought
down the BMRF1 protein. Thus, the BMRF1 protein appears to be
associated with the BBLF4-BSLF1-BBLF2/3 complex via the BALF5 Pol
catalytic subunit.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 4.
Direct interaction between the BALF5 Pol catalytic
subunit and the BBLF4-BSLF1-BBLF2/3 complex in the recombinant
baculovirus expression system. (A) High Five insect cells were
superinfected with the recombinant baculoviruses AcBALF5, AcBBLF4,
AcBSLF1, and AcBBLF2/3. Cell extracts were prepared as described in
Materials and Methods and subjected to immunoprecipitation (I.P.)
analyses. One microgram of the control rabbit IgG or anti-BBLF2/3w IgG
was added to the lysates, and the mixtures were incubated in the
presence of 150 mM NaCl and 1% NP-40. The antigen-antibody complexes
were collected with 20 µg of protein A beads and washed six times
with NET gel buffer containing 500 mM NaCl and 0.1% NP-40. Aliquots of
the immunoprecipitated proteins (10 µl) and lysates (5 µl; Input)
were resolved by SDS-PAGE and analyzed by Western blotting with the
anti-BALF5, anti-BSLF1c, anti-BBLF2/3w, or anti-BBLF4 IgG.
Immunoprecipitated proteins are indicated by arrowheads. (B) High Five
insect cells were superinfected with the recombinant baculoviruses
AcBMRF1, AcBBLF4, AcBSLF1, and AcBBLF2/3, and cell extracts were
prepared and subjected to immunoprecipitation (I.P.) analyses. Five
micrograms of control rabbit IgG or anti-BBLF2/3w IgG beads was added
to the lysates, and the mixtures were incubated. The
antigen-antibody-bead complexes were washed six times with NET gel
buffer containing 500 mM NaCl and 1% NP-40. Aliquots of the
immunoprecipitated proteins, (10 µl) and lysates (5 µl; Input) were
resolved by SDS-PAGE and analyzed by Western blotting with the
anti-BMRF1 mouse monoclonal IgG. (C) High Five cells were superinfected
with the recombinant baculoviruses AcBALF2, AcBBLF4, AcBSLF1, and
AcBBLF2/3, and cell extracts were prepared and subjected to
immunoprecipitation analyses. One microgram of the control rabbit IgG
or anti-BBLF2/3w IgG was added to the lysates, and the mixtures were
incubated. The antigen-antibody complexes were collected with 20 µg
of protein A beads and washed six times with NET gel buffer containing
500 mM NaCl and 1% NP-40. Aliquots of the immunoprecipitated proteins
(10 µl) and lysates (5 µl; Input) were resolved by SDS-PAGE and
analyzed by Western blotting with the anti-BALF2 IgG. (D) Lack of
cross-reactivity of each IgG in immunoprecipitation analyses. High Five
cells were infected with each of the indicated recombinant
baculoviruses. The clarified lysates were prepared and subjected to
immunoprecipitation analyses. One microgram of the indicated IgG was
added to the lysates; the mixtures were incubated in the presence of
150 mM NaCl and 0.1% NP-40 and processed as described above. Aliquots
of the immunoprecipitated proteins (10 µl) and lysates (5 µl;
Input) were resolved by SDS-PAGE and analyzed by Western blotting with
each of the indicated IgGs.
|
|
Next, we tried to show whether the interaction of the BALF2
ssDNA-binding protein and the BBLF4-BSLF1-BBLF2/3 protein complex occurs in the recombinant baculovirus expression system. As expected from experiments with B95-8 cell lysates, the anti-BBLF2/3 IgG did not
precipitate the BALF2 protein from the lysates of cells superinfected with the AcBALF2, AcBBLF4, AcBSLF1, and AcBBLF2/3 recombinant viruses (Fig. 4C). Under the immunoprecipitation
conditions used, the BALF2 ssDNA-binding protein is therefore unlikely
to interact with the BBLF4-BSLF1-BBLF2/3 complex.
The BALF5 Pol catalytic subunit directly interacts with each
component of the BBLF4-BSLF1-BBLF2/3 complex.
To determine
how the BALF5 protein interacts with the BBLF4-BSLF1-BBLF2/3 complex,
pairwise interactions were examined. Extracts from the insect cells
doubly infected with AcBALF5 and either AcBBLF4, AcBSLF1, or
AcBBLF2/3 were prepared and subjected to immunoprecipitation
analyses using the anti-BSLF1c IgG, anti-BBLF2/3w IgG, or
anti-BALF5 IgG (Fig. 5). The anti-BSLF1c
IgG coprecipitated the BALF5 protein from the lysate of cells infected
with AcBALF5 and AcBSLF1 (Fig. 5A) but did not cross-react with the
BALF5 protein (Fig. 4D). Also, the anti-BBLF2/3w IgG could
coprecipitate the BALF5 protein from the lysate of cells infected with
AcBALF5 and AcBBLF2/3 (Fig. 5B). When the cells were doubly infected
with AcBALF5 and AcBBLF4, the anti-BALF5 IgG precipitated the BBLF4 protein as well as the BALF5 protein (Fig. 5C), although the
antibody did not react directly with the BBLF4 protein (Fig. 4D).
Thus, we could demonstrate BALF5-BBLF4, BALF5-BSLF1, and
BALF5-BBLF2/3 subassemblies in the doubly infected insect cells.
These results strongly suggest that the BALF5 protein interacts
directly with each component of the EBV BBLF4-BSLF1-BBLF2/3 complex in
vivo.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 5.
Complex formation between the BALF5 Pol catalytic
subunit and each component of the BBLF4-BSLF1-BBLF2/3 complex. High
Five insect cells were doubly infected with AcBALF5 and AcBSLF1 (A),
AcBBLF2/3 (B), or AcBBLF4 (C). Cell extracts were subjected to
immunoprecipitation (I.P.) analyses using 1 µg of the control rabbit
IgG, anti-BSLF1c IgG, anti-BBLF2/3w IgG, or anti-BALF5 IgG. The
antigen-antibody complexes were collected with 20 µg of protein A
beads and washed with NET gel buffer containing 500 mM NaCl and 1%
NP-40. Aliquots of the immunoprecipitated proteins (10 µl) and
lysates (5 µl; Input) were resolved by SDS-PAGE and analyzed by
Western blotting with the anti-BALF5, anti-BSLF1c, anti-BBLF2/3, or
anti-BBLF4 IgG. Immunoprecipitated proteins are indicated by
arrowheads.
|
|
 |
DISCUSSION |
The multiple steps essential for DNA replication are catalyzed by
a number of proteins whose enzymatic reactions must be closely coordinated. This is most apparent at the replication fork, where both
leading- and lagging-strand synthesis must occur simultaneously for
movement of the replication fork. Therefore, it is not surprising that
replication proteins are frequently isolated as complexes or interact
physically with one another, suggesting that their individual enzymatic
reactions are coordinated via physical associations. The six viral
proteins that account for the basic reactions at the EBV replication
fork are thought to be the EBV Pol holoenzyme consisting of the BALF5
Pol catalytic subunit and the BMRF1 Pol accessory subunit, the BALF2
ssDNA-binding protein, and the EBV putative helicase-primase complex
consisting of the BBLF4, BSLF1, and BBLF2/3 proteins. The specific
interactions that occur among these relatively few proteins appear to
be essential for EBV DNA replication. In this report we have presented
evidence of a novel physical interaction between the EBV DNA Pol
catalytic subunit and the EBV putative helicase-primase complex. Gao et
al. have recently reported that the BALF2 protein may interact with the BBLF4-BSLF1-BBLF2/3 complex (14). Under the same
immunoprecipitation conditions, however, we were not able to detect any
physical interaction between the BALF2 ssDNA-binding protein and the
BBLF4-BSLF1-BBLF2/3 complex, indicating that the BALF5 Pol catalytic
subunit-BBLF4-BSLF1-BBLF2/3 complex interaction is considerably
stronger than that between the BALF2 protein and the
BBLF4-BSLF1-BBLF2/3 complex. Our findings warrant particular attention
because these interactions are thought to coordinate leading- and
lagging-strand DNA synthesis at the EBV replication fork.
Although the immune complexes from the clarified lysate of B95-8 cells
were thoroughly washed with 500 mM NaCl and 1% NP-40, it is possible
that the interaction between the EBV DNA polymerase and the
BBLF4-BSLF1-BBLF2/3 complex was mediated by DNA, even if the
experiments were carried out in the presence of DNase. However, in the
experiments with lysates from insect cells superinfected with AcBALF5,
AcBBLF4, AcBSLF1, and AcBBLF2/3, the anti-BBLF2/3w IgG precipitated all
of the BALF5, BSLF1, BBLF4, and BBLF2/3 proteins (Fig. 4A). Under the
washing conditions used (500 mM NaCl and 1% NP-40), the BALF5 protein
by itself is unable to bind DNA and exhibits no DNA polymerase activity
(41, 43). Therefore, it is reasonable to assume that the
BALF5 Pol catalytic subunit directly interacts with the
BBLF4-BSLF1-BBLF2/3 complex. To demonstrate the direct interaction
between them, domain analyses will be needed.
It is believed that helicases translocate along ssDNA by forming
oligomeric structures, either dimer, hexamer, or multiprotein complexes
(23, 24). The Rep protein of Escherichia coli,
also a member of superfamily I, is believed to form a dimer at
the replication fork (4), whereas the helicases of T4 and T7
bacteriophages and simian virus 40 apparently form hexamers
(10, 17, 28, 34). UL5 (BBLF4 analogue), UL52 (BSLF1
analogue), and UL8 (BBLF2/3 analogue) are three of the seven genes that
are essential for HSV-1 DNA replication. The products of these three
genes form a heterotrimeric complex with helicase and primase
activities (6, 7, 9). The helicase activity presumably
acts to unwind duplex DNA ahead of the progressing replication fork,
thereby producing the open configuration needed for both
continuous and discontinuous strand synthesis. By analogy to
other primases, the primase of HSV-1 presumably initiates discontinuous
DNA synthesis on the lagging strand by providing the oligonucleotide
primers that are elongated by the HSV-1 DNA polymerase. Although the
enzymatic activities of the EBV BBLF4-BSLF1-BBLF2/3 heterotrimeric
complex have yet to be demonstrated, we assume that the
BBLF4-BSLF1-BBLF2/3 complex may act as a helicase and primase like the
HSV-1 UL5-UL52-UL8 complex.
Polymerase and helicase-primase complex interactions have also been
observed in other replication systems. In the case of bacteriophage T7, gene 5 DNA polymerase interacts with the gene 4 helicase-primase via its carboxyl terminus (26, 27), playing an important role in its coordination of leading- and lagging-strand DNA synthesis at the replication fork (8). Also, the
catalytic subunit of the HSV-1 DNA polymerase interacts with the
carboxyl terminus of the UL8 protein of the HSV-1
helicase-primase heterotrimeric complex (25).
Considering these observations, the interaction of the EBV DNA
polymerase with the helicase-primase complex might be central to the
coordination of the leading- and lagging-strand synthesis at the
replication fork of EBV.
We have demonstrated that each component of the EBV BBLF4-BSLF1-BBLF2/3
complex can interact directly with the BALF5 protein. It is not clear
whether a single component of the BBLF4-BSLF1-BBLF2/3 complex and the
BALF5 subunit of the Pol holoenzyme are in constant contact at the
replication fork or whether the interaction is dispersed over a
contiguous region of the complex. If the complex rotates around the DNA
axis as it translocates and unwinds double-stranded DNA, the
interaction with the BALF5 protein may be changing sequentially from
one component in the heterotrimer to the next to relieve torsional
strain. In this case, the BALF5 protein is probably not in constant
contact with a single component of the BBLF4-BSLF1-BBLF2/3 complex. If,
on the other hand, the complex moves along the DNA without any relative
rotation, a constant interaction between the complex and the polymerase
may be maintained as a stable complex. Structural studies are
required to determine where the BBLF4-BSLF1-BBLF2/3 complex
is located and how it is oriented relative to the DNA polymerase at the
replication fork.
The interaction of the helicase-primase and DNA polymerase is required
not only for strand displacement DNA synthesis but also for priming DNA
synthesis on the lagging strand of the replication fork. Little is
known about DNA primase-DNA polymerase interactions involved in the
transition from RNA to DNA synthesis. The bacterophage T7 gene 4A
protein catalyzes the synthesis of tetraribonucleotides at specific
sequences on ssDNA in a template-mediated reaction (36).
These tetraribonucleotides are stabilized on the template by gene 4A
protein until T7 DNA polymerase can use them as primers to initiate DNA
synthesis (26). Such short oligonucleotides prime T7 DNA
polymerase extremely poorly in the absence of the gene 4 protein
(32, 33). The effective use of these tetraribonucleotides by
T7 DNA polymerase in the presence of the gene 4 protein implies that a
specific protein-protein interaction is required. In the case of
bacteriophage T4, a complex of two proteins encoded by genes 41 and 61 is required to catalyze efficiently the synthesis of the
pentaribonucleotide pppACN3, which primes DNA synthesis by T4 DNA
polymerase on ssDNA (22). In a variety of eukaryotic systems, DNA polymerase
has been purified in a tight complex with
DNA primase (3, 5, 35). Interaction between DNA primases and
polymerases may in general play an important role in promoting efficient transition from RNA primer to DNA synthesis on lagging-strand DNA synthesis. Thus, the interaction of the BBLF4-BSLF1-BBLF2/3 complex
and the EBV DNA polymerase at the replication fork may be an important
aspect of the replication process and a possible new target for
antiviral agents.
Considering other DNA replication systems, it is likely that initiation
of lytic-phase EBV DNA replication involves the formation of an
initiation complex at oriLyt. The first step in this process would be
the binding of the BZLF1 protein to its recognition sequences within
the EBV replication origin, oriLyt, to form an initial complex. The
interaction of the BZLF1 protein with the BBLF4-BSLF1-BBLF2/3 complex
reported by Gao et al. (14) supposes that the BZLF1 protein
recruits the viral helicase-primase complex to oriLyt. The BALF2
ssDNA-binding protein appears to interact with the prepriming complex
consisting of the BZLF1-BBLF4-BSLF1-BBLF2/3 complex (14). These proteins together therefore would have the potential to open up
the duplex DNA in the origin region and synthesize RNA primers. The
interaction between the EBV Pol holoenzyme and the BBLF4-BSLF1-BBLF2/3
complex which we have now identified may play an important role in
bringing the viral polymerase into the prepriming complex to initiate
DNA synthesis. It is possible, for example, that binding of the EBV DNA
polymerase to the BBLF4-BSLF1-BBLF2/3 complex reduces the affinity of
the BBLF4-BSLF1-BBLF2/3 complex for BZLF1, allowing the
polymerase-helicase-primase complex to migrate away from oriLyt to the
replication forks.
 |
ACKNOWLEDGMENTS |
We thank M. Hirata, C. Yamada, and T. Yoshida for technical assistance.
This work was supported by grants-in-aid for Scientific Research
on Priority Areas from the Ministry of Education, Science, Sports and
Culture of Japan (11138268 to T.T.) and partly by JSPS-RFTF 97L00703.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Division
of Virology, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya 464-8682, Japan. Phone and fax: 81 52 764 2979. E-mail: ttsurumi{at}aichi-cc.pref.aichi.jp.
 |
REFERENCES |
| 1.
|
Aiyar, A.,
C. Tyree, and B. Sugden.
1998.
The plasmid replication of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element.
EMBO J.
17:6394-6403[CrossRef][Medline].
|
| 2.
|
Baer, R.,
A. T. Bankier,
M. D. Biggin,
P. L. Deininger,
P. J. Farrell,
T. J. Gibson,
G. Hatfull,
G. S. Hudson,
S. C. Satchwell,
C. Séguin,
P. C. Tuffnell, and B. G. Barrell.
1984.
DNA sequence and expression of the B95-8 Epstein-Barr virus genome.
Nature
310:207-211[CrossRef][Medline].
|
| 3.
|
Banks, G. R.,
J. A. Boezi, and I. R. Lehman.
1979.
A high molecular weight DNA polymerase from Drosophila melanogaster embryos.
J. Biol. Chem.
254:9886-9892[Abstract/Free Full Text].
|
| 4.
|
Chao, K., and T. M. Lohman.
1991.
DNA-induced dimerization of the Escherichia coli Rep helicase.
J. Mol. Biol.
221:1165-1181[Medline].
|
| 5.
|
Conaway, R. C., and I. R. Lehman.
1982.
A DNA primase activity associated with DNA polymerase a from Drosophila melanogaster embryos.
Proc. Natl. Acad. Sci. USA
79:2523-2527[Abstract/Free Full Text].
|
| 6.
|
Crute, J. J.,
E. S. Mocarski, and I. R. Lehman.
1988.
A DNA helicase induced by herpes simplex virus type 1.
Nucleic Acids Res.
16:6585-6596[Abstract/Free Full Text].
|
| 7.
|
Crute, J. J.,
T. Tsurumi,
L. Zhu,
S. K. Weller,
P. D. Olivo,
M. D. Challberg,
E. S. Mocarski, and I. R. Lehman.
1989.
Herpes simplex virus 1 helicase-primase: a complex of three herpes-encoded gene products.
Proc. Natl. Acad. Sci. USA
86:2186-2189[Abstract/Free Full Text].
|
| 8.
|
Debyser, Z.,
S. Tabor, and C. C. Richardson.
1994.
Coordination of leading and lagging strand DNA synthesis at the replication fork of bacteriophage T7.
Cell
77:157-166[CrossRef][Medline].
|
| 9.
|
Dodson, M. S.,
J. J. Crute,
R. C. Bruckner, and I. R. Lehman.
1989.
Overexpression and assembly of the herpes simplex virus type 1 helicase-primase in insect cells.
J. Biol. Chem.
264:20853-20838.
|
| 10.
|
Dong, F., and P. H. von Hippel.
1996.
The ATP-activated hexameric helicase of bacteriophage T4 (gp41) forms a stable primosome with a single subunit of T4-coded primase (gp61).
J. Biol. Chem.
271:19625-19631[Abstract/Free Full Text].
|
| 11.
|
Fixman, E. D.,
G. S. Hayward, and S. D. Hayward.
1992.
trans-acting requirements for replication of Epstein-Barr virus ori-Lyt.
J. Virol.
66:5030-5039[Abstract/Free Full Text].
|
| 12.
|
Fixman, E. D.,
G. S. Hayward, and S. D. Hayward.
1995.
Replication of Epstein-Barr virus oriLyt: lack of a dedicated virally encoded origin-binding protein and dependence on Zta in cotransfection assays.
J. Virol.
69:2998-3006[Abstract].
|
| 13.
|
Fujita, M.,
C. Yamada,
H. Goto,
N. Yokoyama,
K. Kuzushima,
M. Inagaki, and T. Tsurumi.
1999.
Cell cycle regulation of human CDC6 Protein: intracellular localization, interaction with the human MCM complex, and CDC2 kinase-mediated hyperphosphorylation.
J. Biol. Chem.
274:25927-25932[Abstract/Free Full Text].
|
| 14.
|
Gao, Z.,
A. Krithivas,
J. E. Finan,
O. J. Semmes,
S. Zhou,
Y. Wang, and S. D. Hayward.
1998.
The Epstein-Barr virus lytic transactivator Zta interacts with the helicase-primase replication proteins.
J. Virol.
72:8559-8567[Abstract/Free Full Text].
|
| 15.
|
Hammerschmidt, W., and B. Sugden.
1988.
Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus.
Cell
55:427-433[CrossRef][Medline].
|
| 16.
|
Harlow, E., and D. Lane.
1988.
Antibodies: a laboratory manual.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 17.
|
Joo, W. S.,
H. Y. Kim,
J. D. Purviance,
K. R. Sreekumar, and P. A. Bullock.
1998.
Assembly of T-antigen double hexamers on the simian virus 40 core origin requires only a subset of the available binding sites.
Mol. Cell. Biol.
18:2677-2687[Abstract/Free Full Text].
|
| 18.
|
Kallin, B.,
L. Sternås,
A. K. Saemundssen,
J. Luka,
H. Jörnvall,
B. Eriksson,
P.-Z. Tao,
M. T. Nilsson, and G. Klein.
1985.
Purification of Epstein-Barr virus DNA polymerase from P3HR-1 cells.
J. Virol.
54:561-568[Abstract/Free Full Text].
|
| 19.
|
Kiehl, A., and D. I. Dorsky.
1995.
Bipartite DNA-binding region of the Epstein-Barr virus BMRF1 product essential for DNA polymerase accessory function.
J. Virol.
69:1669-1677[Abstract].
|
| 20.
|
Kiehl, A., and D. I. Dorsky.
1991.
Cooperation of EBV DNA polymerase and EA-D (BMRF1) in vitro and colocalization in nuclei of infected cells.
Virology
184:330-340[CrossRef][Medline].
|
| 21.
|
Li, J.-S.,
B.-S. Zhou,
G. E. Dutschman,
S. P. Grill,
R.-S. Tan, and Y.-C. Cheng.
1987.
Association of Epstein-Barr virus early antigen diffuse component and virus-specified DNA polymerase activity.
J. Virol.
61:2947-2949[Abstract/Free Full Text].
|
| 22.
|
Liu, C.-C., and B. M. Alberts.
1980.
Pentaribonucleotides of mixed sequence are synthesized and efficiently prime de novo DNA chain starts in the T4 bacteriophage DNA replication system.
Proc. Natl. Acad. Sci. USA
77:5698-5703[Abstract/Free Full Text].
|
| 23.
|
Lohman, T. M.
1993.
Helicase-catalyzed DNA unwinding.
J. Biol. Chem.
268:2269-2272[Abstract/Free Full Text].
|
| 24.
|
Lohman, T. M., and K. P. Bijornson.
1996.
Mechanisms of helicase-catalyzed DNA unwinding.
Annu. Rev. Biochem.
65:169-214[CrossRef][Medline].
|
| 25.
|
Marsden, H. S.,
G. W. McLean,
E. C. Barnard,
G. J. Francis,
K. MacEachran,
M. Murphy,
G. McVey,
A. Cross,
A. P. Abbotts, and N. D. Stow.
1997.
The catalytic subunit of the DNA polymerase of herpes simplex virus type 1 interacts specifically with the C terminus of the UL8 component of the viral helicase-primase complex.
J. Virol.
71:6390-6397[Abstract].
|
| 26.
|
Nakai, H., and C. C. Richardson.
1986.
Interactions of the DNA polymerase and gene 4 protein of bacteriophage T7.
J. Biol. Chem.
261:15208-15216[Abstract/Free Full Text].
|
| 27.
|
Notarnicola, S. M.,
H. L. Mulcahy,
J. Lee, and C. C. Richardson.
1997.
The acidic carboxyl terminus of the bacteriophage T7 gene 4 helicase/primase interacts with T7 DNA polymerase.
J. Biol. Chem.
272:18425-18433[Abstract/Free Full Text].
|
| 28.
|
Patel, S. S., and M. M. Hingorani.
1993.
Oligomeric structure of bacteriophage T7 DNA primase/helicase proteins.
J. Biol. Chem.
268:10668-10675[Abstract/Free Full Text].
|
| 29.
|
Pearson, G. R.,
B. Vroman,
B. Chase,
T. Sculley,
M. Hummel, and E. Kieff.
1983.
Identification of polypeptide components of the Epstein-Barr virus early antigen complex with monoclonal antibodies.
J. Virol.
47:193-201[Abstract/Free Full Text].
|
| 30.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 31.
|
Schepers, A.,
D. Pich, and W. Hammerschmidt.
1996.
Activation of oriLyt, the lytic origin of DNA replication of Epstein-Barr virus, by BZLF1.
Virology
220:367-376[CrossRef][Medline].
|
| 32.
|
Scherzinger, E.,
E. Lanka, and G. Hillenbrand.
1977.
Role of bacteriophage T7 DNA primase in the initiation of DNA strand synthesis.
Nucleic Acids Res.
4:4151-4163[Abstract/Free Full Text].
|
| 33.
|
Scherzinger, E.,
E. Lanka,
G. Morelli,
D. Seiffert, and A. Yuki.
1977.
Bacteriophage-T7-induced DNA-priming protein.
Eur. J. Biochem.
72:543-558[Medline].
|
| 34.
|
Smelkova, N. V., and J. A. Borowiec.
1997.
Dimerization of simian virus 40 T-antigen hexamers activates T-antigen DNA helicase activity.
J. Virol.
71:8766-8773[Abstract].
|
| 35.
|
Stadlbauer, F.,
A. Brueckner,
C. Rehfuess,
C. Eckerskorn,
F. Lottspeich,
V. Förster,
B. Y. Tseng, and H.-P. Nasheuer.
1994.
DNA replication in vitro by recombinant DNA-polymerase-a-primase.
Eur. J. Biochem.
222:781-793[Medline].
|
| 36.
|
Tabor, S., and C. C. Richardson.
1981.
Template recognition sequence for RNA primer synthesis by gene 4 protein of bacteriophage T7.
Proc. Natl. Acad. Sci. USA
78:205-209[Abstract/Free Full Text].
|
| 37.
|
Tsurumi, T.
1991.
Characterization of 3'-to-5' exonuclease activity associated with Epstein-Barr virus DNA polymerase.
Virology
182:376-381[CrossRef][Medline].
|
| 38.
|
Tsurumi, T.
1991.
Primer terminus recognition and highly processive replication by Epstein-Barr virus DNA polymerase.
Biochem. J.
280:703-708.
|
| 39.
|
Tsurumi, T.
1993.
Purification and characterization of the DNA-binding activity of the Epstein-Barr virus DNA polymerase accessory protein BMRF1 gene products, as expressed in insect cells by using the baculovirus system.
J. Virol.
67:1681-1687[Abstract/Free Full Text].
|
| 40.
|
Tsurumi, T.,
T. Daikoku,
R. Kurachi, and Y. Nishiyama.
1993.
Functional interaction between Epstein-Barr virus DNA polymerase catalytic subunit and its accessory subunit in vitro.
J. Virol.
67:7648-7653[Abstract/Free Full Text].
|
| 41.
|
Tsurumi, T.,
T. Daikoku, and Y. Nishiyama.
1994.
Further characterization of the interaction between the Epstein-Barr virus DNA polymerase catalytic subunit and its accessory subunit with regard to the 3'-to-5' exonucleolytic activity and stability of initiation complex at primer terminus.
J. Virol.
68:3354-3363[Abstract/Free Full Text].
|
| 42.
|
Tsurumi, T.,
J. Kishore,
N. Yokoyama,
M. Fujita,
T. Daikoku,
H. Yamada,
Y. Yamashita, and Y. Nishiyama.
1998.
Overexpression, purification and helix-destabilizing properties of Epstein-Barr virus ssDNA-binding protein.
J. Gen. Virol.
79:1257-1264[Abstract].
|
| 43.
|
Tsurumi, T.,
A. Kobayashi,
K. Tamai,
T. Daikoku,
R. Kurachi, and Y. Nishiyama.
1993.
Functional expression and characterization of the Epstein-Barr virus DNA polymerase catalytic subunit.
J. Virol.
67:4651-4658[Abstract/Free Full Text].
|
| 44.
|
Tsurumi, T.,
A. Kobayashi,
K. Tamai,
H. Yamada,
T. Daikoku,
Y. Yamashita, and Y. Nishiyama.
1996.
Epstein-Barr virus single-stranded DNA-binding protein: purification, characterization, and action on DNA synthesis by the viral DNA polymerase.
Virology
222:352-364[CrossRef][Medline].
|
| 45.
|
Wang, Y., and J. D. Hall.
1990.
Characterization of a major DNA-binding domain in the herpes simplex type 1 DNA-binding protein (ICP8).
J. Virol.
64:2082-2089[Abstract/Free Full Text].
|
| 46.
|
Yates, J. L., and N. Guan.
1991.
Epstein-Barr virus-derived plasmids replication only per cell cycle and not amplified after entry into cells.
J. Virol.
65:483-488[Abstract/Free Full Text].
|
| 47.
|
Yokoyama, N.,
K. Fujii,
M. Hirata,
K. Tamai,
T. Kiyono,
K. Kuzushima,
Y. Nishiyama,
M. Fujita, and T. Tsurumi.
1999.
Assembly of the Epstein-Barr virus BBLF4, BSLF1, BBLF2/3 proteins and their interactive properties.
J. Gen. Virol.
80:2879-2887[Abstract/Free Full Text].
|
| 48.
|
Zeng, Y.,
J. Middeldorp,
J. Madjar, and T. Ooka.
1997.
A major DNA binding protein encoded by BALF2 open reading frame of Epstein-Barr virus (EBV) forms a complex with other EBV DNA-binding proteins: DNAase, EA-D, and DNA polymerase.
Virology
239:285-295[CrossRef][Medline].
|
| 49.
|
Zhang, Q.,
Y. Hong,
D. Dorsky,
E. Holley-Guthrie,
S. Zalani,
N. A. Elshiekh,
A. Kiehl,
T. Le, and S. Kenney.
1996.
Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: effects on EBV transcription and lytic replication.
J. Virol.
70:5131-5142[Abstract/Free Full Text].
|
Journal of Virology, March 2000, p. 2550-2557, Vol. 74, No. 6
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Xu, D., Coleman, T., Zhang, J., Fagot, A., Kotalik, C., Zhao, L., Trivedi, P., Jones, C., Zhang, L.
(2007). Epstein-Barr Virus Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication in Primary Effusion Lymphomas. J. Virol.
81: 6068-6078
[Abstract]
[Full Text]
-
Daikoku, T., Kudoh, A., Fujita, M., Sugaya, Y., Isomura, H., Shirata, N., Tsurumi, T.
(2005). Architecture of Replication Compartments Formed during Epstein-Barr Virus Lytic Replication. J. Virol.
79: 3409-3418
[Abstract]
[Full Text]
-
Liao, G., Huang, J., Fixman, E. D., Hayward, S. D.
(2005). The Epstein-Barr Virus Replication Protein BBLF2/3 Provides an Origin-Tethering Function through Interaction with the Zinc Finger DNA Binding Protein ZBRK1 and the KAP-1 Corepressor. J. Virol.
79: 245-256
[Abstract]
[Full Text]
-
Zhang, J., Das, S. C., Kotalik, C., Pattnaik, A. K., Zhang, L.
(2004). The Latent Membrane Protein 1 of Epstein-Barr Virus Establishes an Antiviral State via Induction of Interferon-stimulated Genes. J. Biol. Chem.
279: 46335-46342
[Abstract]
[Full Text]
-
Kudoh, A., Daikoku, T., Sugaya, Y., Isomura, H., Fujita, M., Kiyono, T., Nishiyama, Y., Tsurumi, T.
(2004). Inhibition of S-Phase Cyclin-Dependent Kinase Activity Blocks Expression of Epstein-Barr Virus Immediate-Early and Early Genes, Preventing Viral Lytic Replication. J. Virol.
78: 104-115
[Abstract]
[Full Text]
-
Gershburg, E., Pagano, J. S.
(2002). Phosphorylation of the Epstein-Barr Virus (EBV) DNA Polymerase Processivity Factor EA-D by the EBV-Encoded Protein Kinase and Effects of the L-Riboside Benzimidazole 1263W94. J. Virol.
76: 998-1003
[Abstract]
[Full Text]
-
Liao, G., Wu, F. Y., Hayward, S. D.
(2001). Interaction with the Epstein-Barr Virus Helicase Targets Zta to DNA Replication Compartments. J. Virol.
75: 8792-8802
[Abstract]
[Full Text]